"Adenoviridae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases.
| Descriptor ID |
D000256
|
| MeSH Number(s) |
B04.280.030
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenoviridae".
Below are MeSH descriptors whose meaning is more specific than "Adenoviridae".
This graph shows the total number of publications written about "Adenoviridae" by people in this website by year, and whether "Adenoviridae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 1 | 7 |
| 1997 | 8 | 4 | 12 |
| 1998 | 9 | 3 | 12 |
| 1999 | 5 | 8 | 13 |
| 2000 | 11 | 7 | 18 |
| 2001 | 5 | 11 | 16 |
| 2002 | 8 | 10 | 18 |
| 2003 | 6 | 11 | 17 |
| 2004 | 13 | 11 | 24 |
| 2005 | 11 | 6 | 17 |
| 2006 | 5 | 8 | 13 |
| 2007 | 7 | 7 | 14 |
| 2008 | 6 | 6 | 12 |
| 2009 | 5 | 8 | 13 |
| 2010 | 7 | 3 | 10 |
| 2011 | 4 | 10 | 14 |
| 2012 | 8 | 3 | 11 |
| 2013 | 3 | 7 | 10 |
| 2014 | 3 | 8 | 11 |
| 2015 | 2 | 7 | 9 |
| 2016 | 3 | 4 | 7 |
| 2017 | 5 | 9 | 14 |
| 2018 | 2 | 4 | 6 |
| 2019 | 0 | 3 | 3 |
| 2020 | 4 | 0 | 4 |
| 2021 | 3 | 1 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenoviridae" by people in Profiles.
-
Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity. J Immunother Cancer. 2024 Dec 09; 12(12).
-
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Gu?rin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 Jul; 212(1):74-86.
-
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial. Circ Cardiovasc Interv. 2024 May; 17(5):e014054.
-
Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay. Front Immunol. 2023; 14:1299512.
-
Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies. Sci Adv. 2023 03 29; 9(13):eade6790.
-
Adenoviral gene therapy for bladder cancer. Cell. 2023 03 02; 186(5):893.
-
In Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection. J Vis Exp. 2023 02 10; (192).
-
Acute liver failure and unique challenges of pediatric liver transplantation amidst a worldwide cluster of adenovirus-associated hepatitis. Am J Transplant. 2023 01; 23(1):93-100.
-
In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector. Biomed Pharmacother. 2023 Feb; 158:114189.
-
Longitudinal evaluation of pediatric respiratory infections. J Clin Virol. 2022 03; 148:105084.